Filtros de búsqueda

Lista de obras de

A Distributed International Patient Data Registry for Hairy Cell Leukemia

A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia

artículo científico publicado en 2009

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

artículo científico publicado en 2007

A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).

artículo científico publicado en 2015

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2001

A population-based study of large granular lymphocyte leukemia

artículo científico publicado en 2016

A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

Absolute lymphocyte count predicts overall survival in follicular lymphomas

artículo científico publicado en 2006

Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

artículo científico publicado en 2012

Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

scientific article published on 13 December 2019

Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes.

artículo científico publicado en 2017

Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia

artículo científico publicado en 2010

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

artículo científico publicado en 2017

Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis

artículo científico publicado en 2013

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

artículo científico publicado en 2019

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

artículo científico publicado en 2018

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes

artículo científico publicado en 2020

Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL).

artículo científico publicado en 2016

Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis

artículo científico publicado en 2009

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre

artículo científico publicado en 2018

B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome

artículo científico publicado en 2008

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression

artículo científico publicado en 2009

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia

artículo científico publicado en 2009

CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia

artículo científico publicado en 2017

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

artículo científico publicado en 2008

CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.

artículo científico publicado en 2010

Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL c

artículo científico publicado en 2014

Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia

scientific article published on 01 April 2003

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes

artículo científico publicado en 2013

Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study

artículo científico publicado en 2012

Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease.

artículo científico publicado en 2017

Clinical and radiological responses to oral methotrexate alone or in combination with other agents in Erdheim-Chester disease

artículo científico publicado en 2017

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

scientific article published on 13 June 2019

Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies

artículo científico publicado en 2005

Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis

scientific article published on 11 March 2020

Clinical significance of monoclonal B cells in cerebrospinal fluid

artículo científico publicado en 2005

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

artículo científico publicado en 2007

Commentary: chronic lymphocytic leukemia--the price of progress

artículo científico publicado en 2010

Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families

artículo científico publicado en 2010

Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes

artículo científico publicado en 2012

Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia

artículo científico publicado en 2012

Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia

artículo científico publicado en 2008

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

artículo científico publicado en 2016

Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia

artículo científico publicado en 2018

Current approach to diagnosis and management of chronic lymphocytic leukemia

artículo científico publicado en 2004

Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications

artículo científico publicado en 2000

Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma amongst chronic lymphocytic leukemia patients

artículo científico publicado en 2020

Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma

artículo científico publicado en 2011

Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

artículo científico publicado en 2013

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab

artículo científico publicado en 2008

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia

artículo científico publicado en 2020

Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitors

artículo científico publicado en 2016

Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma.

artículo científico publicado en 2012

Early treatment of high risk chronic lymphocytic leukemia with alemtuzumab, rituximab and poly-(1-6)-beta-glucotriosyl-(1-3)- beta-glucopyranose beta-glucan is well tolerated and achieves high complete remission rates

artículo científico publicado en 2015

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

artículo científico publicado en 2008

Effect of Non-Hodgkin Lymphoma on Survival in Patients With Malignant Fibrous Histiocytoma, Kaposi Sarcoma, and Sebaceous Carcinoma: A SEER Population-Based Study

artículo científico publicado en 2016

Efficacy of biological agents in the treatment of Erdheim-Chester disease.

artículo científico publicado en 2017

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders

artículo científico publicado en 2006

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project

artículo científico publicado en 2014

Etiologies of Extreme Thrombocytosis: A Contemporary Series

artículo científico publicado en 2019

Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2007

Food‐frequency questionnaire‐based estimates of total antioxidant capacity and risk of non‐Hodgkin lymphoma ⬇️

artículo científico publicado el 30 de noviembre de 2011

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia

artículo científico publicado en 2013

Genetic susceptibility variants for chronic lymphocytic leukemia

artículo científico publicado en 2010

Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma

artículo científico publicado en 2007

Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma

artículo científico publicado en 2008

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

artículo científico publicado en 2017

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

scientific journal article

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

artículo científico publicado en 2013

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.

artículo científico publicado en 2010

Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma

artículo científico publicado en 2010

Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

artículo científico publicado en 2011

High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia

artículo científico publicado en 2017

Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.

artículo científico publicado en 2015

Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis

scientific article published on 31 October 2019

Human Pegivirus infection and lymphoma risk and prognosis: a North American study

artículo científico publicado en 2018

Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes

artículo científico publicado en 2015

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

artículo científico publicado en 2019

Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study

artículo científico publicado en 2016

Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients

artículo científico publicado en 2008

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.

artículo científico publicado en 2011

Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center Experience.

artículo científico publicado en 2015

Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels

artículo científico publicado en 2015

Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice

scientific article published on 25 May 2020

Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines

artículo científico publicado en 2014

Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis

artículo científico publicado en 1994

Incidence of leukemia in Olmsted County, Minnesota, 1975 through 1989.

artículo científico publicado en 1994

Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib

scientific article published on 01 September 2020

Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia

artículo científico publicado en 2021

Increased incidence and recurrence rates of nonmelanoma skin cancer in patients with non-Hodgkin lymphoma: a Rochester Epidemiology Project population-based study in Minnesota

artículo científico publicado en 2014

Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia

artículo científico publicado en 2015

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls

artículo científico publicado en 2012

Infectious lymphadenitis in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare, but important, complication

artículo científico publicado en 2014

Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response

artículo científico publicado en 2004

Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia

artículo científico publicado en 2005

Intervention to promote physician well-being, job satisfaction, and professionalism: a randomized clinical trial

artículo científico

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

artículo científico publicado en 2017

Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL).

artículo científico publicado en 2013

Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia

scientific article published on 01 June 2006

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

artículo científico publicado en 2008

Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes

artículo científico publicado en 2013

Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab

artículo científico publicado en 2008

Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project

artículo científico publicado en 2014

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

artículo científico publicado en 2016

Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2006

Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features

artículo científico publicado en 2007

Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia

artículo científico publicado en 2011

N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia

artículo científico publicado en 2009

Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia

artículo científico publicado en 2006

Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial

artículo científico publicado en 2016

Ofatumumab‐based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL) ⬇️

artículo científico publicado el 6 de agosto de 2013

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis

artículo científico publicado en 2018

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness

scientific article published on 01 July 2018

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.

artículo científico publicado en 2017

Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia

artículo científico publicado en 2010

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia

artículo científico publicado en 2009

Periodic fever syndrome with relapsing glomerulonephritis: a case report and teaching points

artículo científico publicado en 2011

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

artículo científico publicado en 2016

Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia

artículo científico publicado en 2012

Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia

artículo científico publicado en 2002

Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia

artículo científico publicado en 2011

Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia

artículo científico publicado en 2009

Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia ⬇️

artículo científico publicado el 5 de noviembre de 2010

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia

artículo científico publicado en 2009

Prevalence and Overall Survival of Low Count Monoclonal B-Cell Lymphocytosis (LC-MBL): A Screening Study of 8,297 Individuals from the Mayo Clinic Biobank

Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia

artículo científico publicado en 2016

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia

scientific article published on April 2008

Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia

artículo científico publicado en 2006

Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients

artículo científico publicado en 2007

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

artículo científico publicado en 2019

Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.

artículo científico publicado en 2017

Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience

artículo científico publicado en 2015

Renal insufficiency is an independent prognostic factor in patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia

artículo científico publicado en 2007

Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma

artículo científico publicado en 2017

Risk of non-Hodgkin lymphoma in association with germline variation in complement genes

artículo científico publicado en 2009

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis

artículo científico publicado en 2015

Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

artículo científico publicado en 2020

Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia

artículo científico publicado en 2013

Solid organ transplant in individuals with monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia

artículo científico publicado en 2015

Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia

artículo científico publicado en 2010

Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population

scientific article published on 12 August 2011

Susceptibility genes and B-chronic lymphocytic leukaemia

artículo científico publicado en 2007

The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender.

artículo científico publicado en 2012

The association of health behaviors with quality of life in lymphoma survivors

artículo científico publicado en 2020

The efficacy of ibrutinib in the treatment of Richter syndrome

artículo científico publicado en 2015

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

scientific article published on 18 March 2020

The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia

artículo científico publicado en 2008

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

artículo científico publicado en 2008

The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor

scientific article published on 23 January 2020

The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation

artículo científico publicado en 2010

Thrombocytopenia after iron dextran administration in a patient with severe iron deficiency anemia

artículo científico publicado en 2000

Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma

artículo científico publicado en 2013

Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone

artículo científico publicado en 2010

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study

artículo científico publicado en 2015

Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index

scientific article published on 12 April 2020

Update on risk-stratified management for chronic lymphocytic leukemia

artículo científico publicado en 2006

Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2014

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test

artículo científico publicado en 2007

Validation of a new prognostic index for patients with chronic lymphocytic leukemia

artículo científico publicado en 2009

Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda